Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 3, 2008, Pages 178-185

  Syed Iqbal, H ^a   Balakrishnan, P ^a   Murugavel, K G ^a   Suniti, Solomon ^a  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

Author keywords

HIV rapid assay; HIV testing algorithm; HIV 2 western blot

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BLOOD SAMPLING; CHROMATOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIRST RESPONSE HIV 1-2.0; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; METHODOLOGY; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

AIDS SERODIAGNOSIS; ALGORITHMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MUREX;

EID: 44949259164     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20238     Document Type: Article

References (36)

1. Simoes E, Babu A, John PG, et al. Evidence for HTLV-III infection in prostitutes in Tamil Nadu (India). Indian J Med Res 1987;85:335-338.
2. Joint United Nations programme on HIV/AIDS (UNAIDS). 2.5 million people in India living with HIV, according to new estimates. 2007. Press release. [Online] http://www.unaids.org/en/MediaCentre/PressMaterials/FeatureStory/ 20070704_India_new_data.asp
3. Solomon S, Kumarasamy N, Ganesh AK, Amalraj RE. Prevalence and risk factors of HIV-1 and HIV-2 infection in urban and rural areas in Tamil Nadu, India. Int J Std AIDS 1998;9:98-103.
4. Syed Iqbal H, Suniti Solomon, Murugavel KG, Sunil Suhas Solomon, Balakrishnan P. Evaluation and diagnostic usefulness of domestic and imported enzyme-linked immunosorbent assays for detection of human immunodeficiency virus type 1 antibody in India. Clin Diagn Lab Immunol 2005;12:1425-1428.
5. Rajesh K, Ramalingam S, Pradeepkumar S, Damodharan K, Sridharan G. Hospital-based evaluation of two rapid human immunodeficiency virus antibody screening tests. J Clin Microbiol 2000;38:3445-3447.
6. World Health Organization. The importance of simple/rapid assays in HIV testing. WHO/UNAIDS recommendations. Wkly Epidemiol Rec 1998;42:321-326.
7. Kannagai R, Prabu K, Vincent AA, Vijayakumar TS, Sridharan G. Performance evaluation of four different kits available in the Indian market, for the rapid detection of HIV antibody. Indian J Med Microbiol 2003;21:193-195.
8. Aidoo S, Ampofo WK, Brandful JAM, et al. Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa. J Clin Microbiol 2001;39:2572-2575.
9. Palmer CJ, Dubon JM, Koenig E, et al. Field evaluation of the determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol 1999;37:3698-3700.
10. Rodrigo-Rodrigues R, Da Silva Pinto Neto LF, Carla BC, Valeria PC, Reynaldo D. Performance characteristic of a rapid new immunochromatographic test for detection of antibodies to human immunodeficiency virus. Clin Diagn Lab Immunol 2003;10:303-307.
11. Kagulire SC, Stamper PD, Opendi P, et al. Performance of two commercial immunochromatographic assays for rapid detection of antibodies specific to human immunodeficiency virus types 1 and 2 in serum and urine samples in a rural community-based research setting (Rakai, Uganda). Clin Vaccine Immunol 2007;14:738.
12. Vijayakumar TS, David S, Selvaraj K, Viswanathan T, Kannangai R, Sridharan G. Performance of a rapid immunochromatographic screening test for detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2: experience at a tertiary care hospital in South India. J Clin Microbiol. 2005;43:4194-4196.
13. Solomon S, Kouyoumdjian FG, Cecelia AJ, James R, James L, Kumarasamy N. Why are people getting tested? Self-reported reasons for seeking voluntary counseling and testing at a clinic in Chennai, India. AIDS Behav 2006;10:415-420.
14. Gerald SJ, George R. AIDS testing, methodology and management issues. New York: Spring Verlag; 1992. p 66.
15. Sudha T, Teja VD, Gopal M, Rajesh M, Lakshmi V. Comparative evaluation of TRI-DOT Rapid HIV test with fourth-generation ELISA for the detection of human immunodeficiency virus. Clin Microbiol Infect 2005;11:850-852.
16. Thakral B, Saluja K, Sharma RR, Marwaha. Algorithm for recall of HIV reactive Indian blood donors by sequential immunoassays enables selective donor referral for counseling. J Postgrad Med 2006;52:106-110.
17. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-562.
18. Matter L, Germann D. Detection of human immunodeficiency virus (HIV) type 1 antibodies by new automated microparticle enzyme immunoassay for HIV types 1 and 2. J Clin Microbiol 1995;33:2338-2341.
19. Pyra H, Boni J, Schupbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci USA 1994;91:1544-1548.
20. Cedric M, Pontiano K, Amato O, James AG. Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in Africa. Int J Epidemiol 2002;31:985-990.
21. Christopher M, Geoffrey E, Stephen P, et al. Highly active antiretroviral therapy and viral response in HIV Type 2 infection. Clin Infect Dis 2004;38:1771-1779.
22. Jallow S, Kaye S, Alabi A, et al. Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia. AIDS 2006;20:1455-1458.
23. Rodes B, Holguin A, Soriano V, Dourana M, Mansinho K, Antunes F. Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. J Clin Microbiol 2000;38:1370-1374.
24. Ming Guan. Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus. Clin Vaccine Immunol 2007;16:649.
25. Rae FM, Healey DS, Best SJ, Dax EM. Characterization of HIV-2 Western blot reactivity. Int Conf AIDS; 1993. Abstract PO-A31-0759.
26. World Health Organization and Joint United Nations Programme on HIV/AIDS. Guidelines for using HIV testing technologies in surveillance guidelines for using HIV testing technologies in surveillance: selection, evaluation, and implementation. WHO/CDS/CSR/EDC/2001.16, UNAIDS/01.22E. 2001. [Online] http://www.who.int/hiv/pub/surveillance/en/guidelinesforUsingHIVTestingTechs_E. pdf.
27. Granade TC, Parekh BS, Tih PM, et al. Evaluation of rapid prenatal human immunodeficiency virus testing in rural Cameroon. Clin Diagn Lab Immunol 2005;12:855-860.
28. Wright RJ, Stringer JS. Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings. Am J Prev Med 2004;27:42-48.
29. Meless H, Tegbaru B, Messele T, et al. Evaluation of rapid assays for screening and confirming HIV-1 infection in Ethiopia. Ethiop Med J 2002;40:27-36.
30. Singer DE, Kiwanuka N, Serwadda D, et al. Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays. J Clin Microbiol 2005;43:5312-5315.
31. World Health Organization and Joint United Nations Programme on HIV/AIDS. Guidance on provider-initiated HIV testing and counseling in health facilities. 2007. [Online] http://whqlibdoc.-who.int/publications/2007/9789241595568_eng. pdf.
32. Genesca J, Jett BW, Epstein JS, et al. What do Western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet 1989;2:1023-1025.
33. Midthun K, Garrison L, Clements ML, et al. Frequency of indeterminate Western blot tests in healthy adults at low risk for human immunodeficiency virus infection. J Infect Dis 1990;162:1379-1382.
34. Mortimer PP. The fallibility of HIV Western blot. Lancet 1991;337:286-287.
35. Sato PA, Maskill WJ, Tamashiro H, Heymann DL. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot. Bull World Health Organ 1994;72:129-134.
36. Piquet Y, Ivanovic Z, Laperche S, et al. Nucleic acid amplification testing detection of an HIV-1 infection in a blood donor during the preseroconversion window period. Transfus Med 2007;17:147-148.